Order Article Reprints

Garcia E, Osté MCJ, Bennett DW, Jeyarajah EJ, Shalaurova I, Gruppen EG, Hazen SL, Otvos JD, Bakker SJL, Dullaart RPF, et al. High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study. Journal of Clinical Medicine. 2019; 8(11):1813. https://doi.org/10.3390/jcm8111813

Garcia, Erwin, Maryse C. J. Osté, Dennis W. Bennett, Elias J. Jeyarajah, Irina Shalaurova, Eke G. Gruppen, Stanley L. Hazen, James D. Otvos, Stephan J. L. Bakker, Robin P.F. Dullaart, and et al. 2019. "High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study" Journal of Clinical Medicine 8, no. 11: 1813. https://doi.org/10.3390/jcm8111813

Garcia, E., Osté, M. C. J., Bennett, D. W., Jeyarajah, E. J., Shalaurova, I., Gruppen, E. G., Hazen, S. L., Otvos, J. D., Bakker, S. J. L., Dullaart, R. P. F., & Connelly, M. A. (2019). High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study. Journal of Clinical Medicine, 8(11), 1813. https://doi.org/10.3390/jcm8111813